Literature DB >> 24707929

The development and implementation of the Chicago public schools emergency EpiPen® policy.

Emily H Zadikoff1, Stephanie A Whyte, Lilliana Desantiago-Cardenas, Blair Harvey-Gintoft, Ruchi S Gupta.   

Abstract

BACKGROUND: Food allergy affects 1 in 13 children, or 2 children per classroom. Food allergies are the leading cause of anaphylaxis, a severe allergic reaction that can result in death. In fact, 25% of first-time anaphylactic reactions among children occur in school. To address this, the Chicago Public Schools (CPS) Office of Student Health and Wellness amended the Administration of Medication Policy in 2012.
METHODS: The CPS Administration of Medication Policy was reviewed and analyzed.
RESULTS: The policy allows all CPS district schools to be stocked with EpiPens and authorizes school nurses to administer them to students that the nurse in good faith professionally believes is having a first-time anaphylactic reaction. Although the policy has proven effective, CPS faces challenges during implementation. CPS school nurse coverage is low, and therefore, there are times when no nurse is onsite to administer EpiPen treatment to a student experiencing a first-time reaction.
CONCLUSIONS: This landmark policy provides quick and easy access to lifesaving treatment and protects nurses from liability in the event of an anaphylactic emergency. A challenge to this policy's utilization includes the lack of funding for daily nurse coverage in each school.
© 2014, American School Health Association.

Entities:  

Keywords:  epinephrine autoinjectors; food allergy; health policy; legislation; safety and emergency care

Mesh:

Substances:

Year:  2014        PMID: 24707929     DOI: 10.1111/josh.12147

Source DB:  PubMed          Journal:  J Sch Health        ISSN: 0022-4391            Impact factor:   2.118


  7 in total

1.  Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis.

Authors:  Marcus S Shaker; Matthew J Greenhawt
Journal:  JAMA Pediatr       Date:  2019-02-01       Impact factor: 16.193

2.  Impact of school peanut-free policies on epinephrine administration.

Authors:  Lisa M Bartnikas; Michelle F Huffaker; William J Sheehan; Watcharoot Kanchongkittiphon; Carter R Petty; Robert Leibowitz; Marissa Hauptman; Michael C Young; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol       Date:  2017-03-25       Impact factor: 10.793

Review 3.  A National Review of State Laws for Stock Epinephrine in Schools.

Authors:  Anna Volerman; Claire Brindley; Nancy Amerson; Tiffanie Pressley; Nikki Woolverton
Journal:  J Sch Health       Date:  2021-11-25       Impact factor: 2.118

4.  School nurse reported supply and administration of naloxone in schools.

Authors:  Catherine C McDonald; Jennifer Pinto-Martin; Peggy Compton; Madeleine Parikh; Zachary F Meisel
Journal:  Public Health Nurs       Date:  2020-02-24       Impact factor: 1.462

Review 5.  Update on the usage and safety of epinephrine auto-injectors, 2017.

Authors:  Larry S Posner; Carlos A Camargo
Journal:  Drug Healthc Patient Saf       Date:  2017-03-21

6.  2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

Authors:  F Estelle R Simons; Motohiro Ebisawa; Mario Sanchez-Borges; Bernard Y Thong; Margitta Worm; Luciana Kase Tanno; Richard F Lockey; Yehia M El-Gamal; Simon Ga Brown; Hae-Sim Park; Aziz Sheikh
Journal:  World Allergy Organ J       Date:  2015-10-28       Impact factor: 4.084

7.  Anaphylaxis management: a survey of school and day care nurses in Lebanon.

Authors:  Tamar Avedissian; Gladys Honein-AbouHaidar; Nuhad Dumit; Nathalie Richa
Journal:  BMJ Paediatr Open       Date:  2018-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.